Replies to post #382 on Contrafect Corp (CFRX)

[BooDog]

Watching ContraFect Shares; Zacks Small-Cap Research Sets $23 Valuation
10:07 am ET November 30, 2021 (Benzinga) Print
Latest Ratings for CFRX DateFirmActionFromTo

Sep 2021SVB LeerinkInitiates Coverage OnOutperform Mar 2021WBB SecuritiesInitiates Coverage OnSpeculative Buy Jun 2020Cantor FitzgeraldInitiates Coverage OnOverweight

View More Analyst Ratings for CFRX
View the Latest Analyst Ratings

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

The company had nothing to do with the $23 valuation.

If I had that answer this would probably be the only bio stock in my portfolio. :-)

Thinking they'll see at least $7 - $10 in 2022. 2nd half.